Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
01/2009
01/01/2009US20090004174 Fusion Proteins
01/01/2009US20090004157 Mature type-1 polarized dendritic cells with enhanced il-12 production and methods of serum-free production and use
01/01/2009US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE
12/2008
12/31/2008WO2009003061A1 Methods and compositions regarding polychalcogenide compositions
12/31/2008WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists
12/31/2008WO2009001915A1 Substituted imidazole compound and use thereof
12/31/2008WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY
12/31/2008WO2009001673A1 Atp-containing immunoadjuvant
12/31/2008WO2009001545A1 Method for detection or treatment of graft versus host disease
12/31/2008WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides
12/31/2008WO2009000066A1 Vaccine against clostridium perfringens
12/31/2008WO2008140782A3 Compounds for enzyme inhibition
12/31/2008WO2008135419A3 Anti-il-6-agents for improving primary functioning of allogenic grafts
12/31/2008WO2008123796A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
12/31/2008WO2008110868A3 Proliferated islets
12/31/2008WO2008091954B1 Optimized cd40 antibodies and methods of using the same
12/31/2008WO2008091954A4 Optimized cd40 antibodies and methods of using the same
12/31/2008WO2008037421A3 Pharmaceutical compositions comprising an s1p modulator
12/31/2008WO2008023278A8 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain
12/31/2008WO2008003978A3 Dioxo-alkanes and dioxo-alkenes
12/31/2008EP2009027A1 Anti-CD40 monoclonal antibody
12/31/2008EP2009018A2 T cell antigen receptor peptides
12/31/2008EP2008994A1 New crystalline form IV of agomelatine, method of preparing same and pharmaceutical compositions containing same
12/31/2008EP2008993A1 New crystalline form III of agomelatine, method of preparing same and pharmaceutical compositions containing same
12/31/2008EP2008657A2 Use of rapamycin derivatives in vasculopathies
12/31/2008EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides
12/31/2008EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol
12/31/2008EP2008532A1 Method for production of capsinoid-containing beverage/food
12/31/2008EP2007817A2 Water soluble beta-glucan, glucosamine, and n-acetylglucosamine compositions and methods for making the same
12/31/2008EP2007809A1 Glycosylated antibodies
12/31/2008EP2007772A1 Thiazolyl-dihydroquinazolines
12/31/2008EP2007735A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
12/31/2008EP2007409A1 Regulation of immune responses by modulation of the function of antigen presenting cells
12/31/2008EP1455817B1 Staphylococcus aureus exopolysaccharide and process
12/31/2008EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/31/2008EP1412503B1 A fusion protein
12/31/2008EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
12/31/2008EP1406867B1 Thiolalkyl benzoic acid derivatives
12/31/2008EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
12/31/2008EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
12/31/2008EP1339864B1 Process for the production of piperidine derivatives with microorganisms
12/31/2008EP1324756B1 Fatty acid analogues for the treatment of proliferative skin disorders
12/31/2008EP1309587B1 Cinnoline compounds
12/31/2008EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof
12/31/2008EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/31/2008EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies
12/31/2008EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis
12/31/2008EP1028751B1 Methods and compositions comprising glycoprotein glycoforms
12/31/2008EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
12/31/2008CN101336112A Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
12/31/2008CN101333256A Human antibodies that bind human il-12 and methods for producing
12/31/2008CN101333255A BP180 single chain antibody of humanized anti-bullous pemphigoid antigen
12/31/2008CN101333251A Artificial zinc finger protein transcription factor capable of starting A20 gene expression and use
12/31/2008CN101333201A Crystal of needle-shaped medical substance and use thereof, medicine composite containing the crystal
12/31/2008CN101332266A Medicinal wine of sixteen ingredients with Rehmannia
12/31/2008CN101332259A Cordycepin polysaccharide buccal tablet and preparation method thereof
12/31/2008CN101332212A Aweto micropowder tablet and preparation method thereof
12/31/2008CN101332186A Medicine composition for injecting triamcinolone acetonide palmitate lipid microsphere and preparation method thereof
12/31/2008CN101332180A Melbex eye drops and preparation method thereof
12/31/2008CN101332169A Preparation method of thymopentin formulation for nasal administration
12/31/2008CN101331943A Production method of freeze-dry instant health wood-frog oil
12/31/2008CN101331912A Mixed type biology feed additive and preparation method thereof
12/31/2008CN101331906A Drink containing Congrong and coffee
12/31/2008CN100447244C BAFF receptor (BCMA), immunoregulatory agent
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447141C Hetero-bicyclic crf antagonists
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446811C Composition comprising immunogenic microparticles
12/31/2008CN100446783C Method for preparing injection of astragalus
12/31/2008CA2728386A1 Nasal and ophthalmic delivery of aqueous corticosteroid solutions
12/31/2008CA2692332A1 Method for detection or treatment of graft versus host disease
12/31/2008CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008CA2685533A1 Vaccine against clostridium perfringens
12/30/2008US7470789 Anhydrous crystalline fexofenadine hydrochloride; H1 receptor antagonist; antihistaminic drug; reduction of ketonic form, salt formation
12/30/2008US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470704 Benzonaphthyridines
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470698 Adenosine A3 receptor modulators
12/30/2008US7470697 E.g.,1-(2-(dimethylamino)ethyl)-3-(4-fluorophenyl)-1-(5-(2,3,4,5-tetrahydro-2,4-dioxo-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidin-6-yl)pyridin-2-yl)urea; antidiarrhea and -ischemic agents; antidiabetic agents/insulin-resistance; asthma; antiallergens; obesity; autoimmune diseases; reperfusion injuries
12/30/2008US7470687 Aryl oximes
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470506 Fitness assay and associated methods
12/30/2008US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2282378C Pharmaceutical composition
12/30/2008CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
12/30/2008CA2250295C Water soluble paclitaxel prodrugs
12/30/2008CA2245545C Vaccines against varicella zoster virus gene 63 product
12/30/2008CA2215190C Aryl-ester phosphoramidate derivatives of nucleosides
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/30/2008CA2144425C Microparticules bearing antigens and their use for the introduction of humoral and cell responses
12/30/2008CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules
12/25/2008US20080319173 Blood group antigen fusion polypeptides and methods of use thereof
12/25/2008US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 1172